Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?—A Study in Patients Treated with Methotrexate and an Anti-TNFα Agent
Table 1
Demographic and clinical data of the patients at baseline.
Patients with RA
Patients with PsA
MTX group
Etanercept group
MTX group
Etanercept group
Patient, (females)
7 (5)
5 (4)
5 (2)
5 (1)
Age, mean (SD)
45.7 (11.7)
60.0 (10)
45.4 (14.1)
50.2 (11)
Disease duration (months), mean (SD)
1.7 (0.2)
26.8 (9.5)
1.8 (0.3)
33 (9.5)
DAS28, mean (SD)
6.6 (0.9)
6.7 (0.9)
5.4 (0.7)
5.3 (0.6)
BMD of the examined joint, mean (SD)
0.291 (0.067)
0.319 (0.028)
0.340 (0.018)
0.363 (0.057)
PDUS: power Doppler US. DAS values between groups were not statistically significant.